Virtually all individuals identified as having obesity based on body mass index (BMI) also had confirmed excess adiposity, ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

New research being presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that ...

Nearly all U.S. adults with obesity as diagnosed by BMI also have an elevated waist circumference or excess body fat, ...

As GLP-1s quiet the constant hum of hunger, are they a permanent pharmaceutical crutch, or can they create space to let us ...

A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...

When a patient with obesity reports a new symptom, many physicians are quick to focus on the excess weight without exploring alternative reasons. Wrong approach, experts said.

Neuroscientists at Virginia Tech’s Fralin Biomedical Research Institute at VTC will investigate how obesity influences brain ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and ...

High sodium intake is linked to greater obesity risk, particularly in women, even when it comes from everyday foods. New ...

A group of Democratic senators are calling on Health and Human Services Secretary Robert F. Kennedy Jr. to keep a proposed ...

A clinical practice guideline that stresses a multidisciplinary approach is intended to help clinicians manage obesity in ...